Search

everythinglearnresearchcommunity

for

Search:↓

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

People with Alopecia areata often have lower vitamin D levels, which may be linked to the severity of their condition.

Zinc levels are not significantly linked to the presence or severity of alopecia areata.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

New grading scale accurately measures hair loss severity and treatment effectiveness.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Epinephrine does not significantly affect the severity of hair loss after surgery.

Acne severity in women with PCOS is significantly associated with their serum LH/FSH ratio.

Hair loss severity relates to increased miniaturization in female pattern hair loss.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Dovobet ointment used overnight effectively reduces scalp psoriasis severity and itch.

Androgenetic alopecia severity does not affect COVID-19 severity.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

The MDhair app accurately assesses hair loss severity with 94% accuracy.

Female pattern hair loss severity is linked to physical signs of high androgens, not blood hormone levels.

Hair loss severity is linked to depression, not anxiety, in Filipino men, with older, less educated men with more hair loss at higher risk.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Gender affects the symptoms and severity of systemic lupus erythematosus.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Testosterone may influence COVID-19 severity and outcomes.